Literature DB >> 25747853

JunB and PTEN in prostate cancer: 'loss is nothing else than change'.

P Birner1, G Egger1, O Merkel2, L Kenner3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25747853      PMCID： PMC4356347          DOI： 10.1038/cdd.2014.232

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  23 in total

Review 1.  Signal transduction by the JNK group of MAP kinases.

Authors:  R J Davis
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

2.  Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis.

Authors:  Xiaoqian Ma; Angelique C Ziel-van der Made; Binha Autar; Hetty A van der Korput; Marcel Vermeij; Petra van Duijn; Kitty B Cleutjens; Ronald de Krijger; Paul Krimpenfort; Anton Berns; Theo H van der Kwast; Jan Trapman
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

3.  Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins.

Authors:  Rainer Zenz; Robert Eferl; Lukas Kenner; Lore Florin; Lars Hummerich; Denis Mehic; Harald Scheuch; Peter Angel; Erwin Tschachler; Erwin F Wagner
Journal:  Nature       Date:  2005-09-15       Impact factor: 49.962

4.  Increased expression of osteopontin contributes to the progression of prostate cancer.

Authors:  Ani C Khodavirdi; Zhigang Song; Shangxin Yang; Chen Zhong; Shunyou Wang; Hong Wu; Colin Pritchard; Peter S Nelson; Pradip Roy-Burman
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

5.  JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression.

Authors:  E Passegué; E F Wagner
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

6.  Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.

Authors:  Zhenbang Chen; Lloyd C Trotman; David Shaffer; Hui-Kuan Lin; Zohar A Dotan; Masaru Niki; Jason A Koutcher; Howard I Scher; Thomas Ludwig; William Gerald; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

7.  Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage.

Authors:  E Passegué; W Jochum; M Schorpp-Kistner; U Möhle-Steinlein; E F Wagner
Journal:  Cell       Date:  2001-01-12       Impact factor: 41.582

8.  The role of c-Jun and c-Fos expression in androgen-independent prostate cancer.

Authors:  Joanne Edwards; N Sarath Krishna; Rono Mukherjee; John M S Bartlett
Journal:  J Pathol       Date:  2004-10       Impact factor: 7.996

Review 9.  Common features of chromatin in aging and cancer: cause or coincidence?

Authors:  Linda Zane; Vivek Sharma; Tom Misteli
Journal:  Trends Cell Biol       Date:  2014-08-04       Impact factor: 20.808

10.  Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.

Authors:  Shunyou Wang; Jing Gao; Qunying Lei; Nora Rozengurt; Colin Pritchard; Jing Jiao; George V Thomas; Gang Li; Pradip Roy-Burman; Peter S Nelson; Xin Liu; Hong Wu
Journal:  Cancer Cell       Date:  2003-09       Impact factor: 31.743
View more
  2 in total

Review 1.  Tackling cellular senescence by targeting miRNAs.

Authors:  Zehua Wang; Jianwen Gao; Congjian Xu
Journal:  Biogerontology       Date:  2022-06-21       Impact factor: 4.284

2.  MicroRNA and Transcription Factor Gene Regulatory Network Analysis Reveals Key Regulatory Elements Associated with Prostate Cancer Progression.

Authors:  Mehdi Sadeghi; Bijan Ranjbar; Mohamad Reza Ganjalikhany; Faiz M Khan; Ulf Schmitz; Olaf Wolkenhauer; Shailendra K Gupta
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.